McGill Alert / Alerte de McGill

Updated: Mon, 07/15/2024 - 16:07

Gradual reopening continues on downtown campus. See Campus Public Safety website for details.

La réouverture graduelle du campus du centre-ville se poursuit. Complément d'information : Direction de la protection et de la prévention.

Funded projects

The Neuro Partnerships Program envelope of $3.1 million is available until 2023. Under this program, Healthy Brains, Healthy Lives (HBHL) provides 1:1 matching funds for projects with a high potential impact on biopharmaceutical research through existing programs offered by the Ministère de l'Économie et de l'Innovation (MEI). Co-funding is available for up to 40% of the total project cost. MEI co-funding is available through CQDM Quantum Leap and SynergiQc programs; and the MEDTEQ Industrial Consortium for Research and Innovation in Medical Technologies. Read more about this program and the evaluation process.

Theme Principal Investigator MEI partner  Other partners Project title

Funding received


Philippe Séguéla


Neurasic Therapeutics

The Jewish Community Foundation of Montreal


Discovery of Analgesic Drugs Targeting the Acid-Sensing Ion Channel Family.

Total: $1,035,505

HBHL: $200,000


Etienne de Villers Sidani




Promoting BEST (BEtter, Faster, Longer, STronger) Walking for People with Parkinsons

Total: $282,477

HBHL: $66,276


Rosemary Bagot


Cubed Biotech

Ludmer Family Foundation

Revealing the neural circuit mechanisms of psilocybin in a depression-relevant brain circuit

Total: $525,000

HBHL: $200,000


Blake Richards


BIOS Santé


Closed loop AI-controlled neural stimulation for treating chronic conditions

Total: $903,585

HBHL: $129,500


Jeremy Cooperstock


Haply Robotics

Kinesthetic interaction device and multimodal authoring tool to support audio-haptic rendering of graphical content for blind and low-vision users


Total: $262,467

HBHL: $56,438

2 Brian Chen CQDM-Quantum Leap

The Research Institute of the McGill University Health Centre (RI-MUHC)

Brain Canada

A drug-screening platform to increase protein expression levels for the treatment of neurological disorders.

Total: $1,495,789

HBHL: $580,000

2 Philippe Gros CQDM-SynergiQc

Corbin Therapeutics

Brain Canada

Exploitation of a new pharmacological target for the development and validation of new anti-inflammatory drugs.

Total: $1,582,821

HBHL: $550,000

3 Alain Ptito MEDTEQ-Impact

Saccade Analytics

Fondation NeuroTrauma Marie-Robert


Advanced Nystagmus System (ANS™) as objective diagnostic tool for mild traumatic brain injury (mTBI) and concussion: A validation

study using structural and functional magnetic resonance imaging.

Total: $216,377

HBHL: $51,322

2 Jean-Paul Soucy MEDTEQ-Impact

Optina Diagnostics


Collaborative Health Research Projects

Evaluation of a radiomic approach based on hyperspectral retinal imaging to predict the cerebral amyloid status for the diagnosis of Alzheimer’s disease.

Total: $881,578

HBHL: $208,757

1 Manuela Ferrari (previously, Outi Linnaranta) MEDTEQ-Impact

Aifred Health

Douglas Hospital

Implementation of a digital mental health tool in an Urban and Rural Setting – Optimizing Usability and Data Quality.

Total: $88,104

HBHL: $21,000

1 Yasser Iturria-Medina MEDTEQ-Impact

Arctic Fox AI

MGH Foundation

Data-driven Biomarker Based Alzheimer’s Disease Progression Composite Score.

Total: $120,498

HBHL: $42,000

2 David Juncker CQDM-Quantum Leap Nplex Biosciences The 200-plex nano-ELISA: a next-generation immuno-proteomic technology for biomarker and drug discovery.

Total: $845,484

HBHL: $200,000

2 Thomas Durcan CQDM-Quantum Leap Brain Canada Development of a high throughput 3D microphysiological platform for rapid automated assessment of human brain organoids response to drugs targeting neurological disorders.

Total: $1,755,736

HBHL: $600,000

1 Blake Richards MEDTEQ-Impact


Bios Santé

Development of an AI-controlled closed-loop neuromodulation system for chronic conditions

Total: $392,647


2 Thomas Durcan CQDM-SynergiQc

Raya Therapeutique

Eikonizo Therapeutics

The preclinical development of 5 molecules for Amyotrophic Lateral Sclerosis and other neurodegenerative

Total: $1,938,890

HBHL: $200,000

Back to top